JAK3-IN-17 is an orally active JAK3 inhibitor with an IC50 of 14.56 nM. It demonstrates anti-inflammatory activity by inhibiting the production of IL-2 and IL-6 in a DNCB-induced mouse model of atopic dermatitis.
Molecular Weight:
358.37
Formula:
C21H15FN4O
Target:
JAK
T207315
* VAT and and shipping costs not included. Errors and price changes excepted
